Accelerating Science and Technology

Friends of Cancer Research is our country's leading voice in advocating for policies and solutions that will get treatments to patients in the safest and quickest way posible.

Read More

Breakthrough Therapies In Action

Since President Obama signed the Breakthrough Therapy designation into law as part of the Food and Drug Administration Safety and Innovation Act, there have already been nine designations announced.

Read More

Friends Hosts Breakthrough Briefing

Senator Michael Bennet gave opening remarks at our July briefing on Breakthrough Therapy

Read More

Download the 2012 Annual Report

Friends of Cancer Research's 2012 Annual Report is now available for download.

Read More

17th Annual Cancer Leadership Awards Reception

Friends Honors Governor Martin O'Malley, Governor Bob McDonnell, and philanthropist Sherry Lansing 

Read More

Interview with Francis Collins

National Institutes of Health Director Francis Collins talks about personalized medicine, sequestration, and the future of biomedical research in America on our new forum, Engaging Innovation.

Read More

Breakthrough Designations

View More

Mydicar - (Celladon)

for reducing hospitalizations for heart failure in NYHA class III or IV chronic heart failure patients


Bexsero - (Novartis)

a vaccine for meningitis B


LDK378 - (Novartis)

for the treatment of non-small cell lung cancer


Recent Blogs

Dr. William W. Chin, Executive Vice President of Scientific and Regulatory Affairs for PhRMA, talks about his experience with public-private partnerships.


"There isn't a day where I'm not overwhelmed by how many people are dealing with this disease, and that's what drives all of our work at Friends of Cancer Research."

Ellen Sigal,
Chair, Friends of Cancer Research